You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

List of Excipients in API pramoxine hydrochloride and hydrocortisone acetate

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing pramoxine hydrochloride and hydrocortisone acetate

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824	CETYL ALCOHOL
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824	GLYCERYL MONOSTEARATE
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824	ISOBUTANE
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824	LAURETH-23
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824	METHYLPARABEN
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824	PEG-100 STEARATE
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824	POLYOXYL 40 STEARATE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for pramoxine hydrochloride and hydrocortisone acetate

Excipient focus: CETYL ALCOHOL

pramoxine hydrochloride and hydrocortisone acetate drug variants containing CETYL ALCOHOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824
>Company	>Ingredient	>NDC

pramoxine hydrochloride and hydrocortisone acetate drug variants not containing CETYL ALCOHOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: GLYCERYL MONOSTEARATE

pramoxine hydrochloride and hydrocortisone acetate drug variants containing GLYCERYL MONOSTEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824
>Company	>Ingredient	>NDC

pramoxine hydrochloride and hydrocortisone acetate drug variants not containing GLYCERYL MONOSTEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: ISOBUTANE

pramoxine hydrochloride and hydrocortisone acetate drug variants containing ISOBUTANE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824
>Company	>Ingredient	>NDC

pramoxine hydrochloride and hydrocortisone acetate drug variants not containing ISOBUTANE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LAURETH-23

pramoxine hydrochloride and hydrocortisone acetate drug variants containing LAURETH-23

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824
>Company	>Ingredient	>NDC

pramoxine hydrochloride and hydrocortisone acetate drug variants not containing LAURETH-23

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: METHYLPARABEN

pramoxine hydrochloride and hydrocortisone acetate drug variants containing METHYLPARABEN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824
>Company	>Ingredient	>NDC

pramoxine hydrochloride and hydrocortisone acetate drug variants not containing METHYLPARABEN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PEG-100 STEARATE

pramoxine hydrochloride and hydrocortisone acetate drug variants containing PEG-100 STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824
>Company	>Ingredient	>NDC

pramoxine hydrochloride and hydrocortisone acetate drug variants not containing PEG-100 STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYOXYL 40 STEARATE

pramoxine hydrochloride and hydrocortisone acetate drug variants containing POLYOXYL 40 STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824
>Company	>Ingredient	>NDC

pramoxine hydrochloride and hydrocortisone acetate drug variants not containing POLYOXYL 40 STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPANE

pramoxine hydrochloride and hydrocortisone acetate drug variants containing PROPANE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824
>Company	>Ingredient	>NDC

pramoxine hydrochloride and hydrocortisone acetate drug variants not containing PROPANE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPYLENE GLYCOL

pramoxine hydrochloride and hydrocortisone acetate drug variants containing PROPYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824
>Company	>Ingredient	>NDC

pramoxine hydrochloride and hydrocortisone acetate drug variants not containing PROPYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPYLPARABEN

pramoxine hydrochloride and hydrocortisone acetate drug variants containing PROPYLPARABEN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824
>Company	>Ingredient	>NDC

pramoxine hydrochloride and hydrocortisone acetate drug variants not containing PROPYLPARABEN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TROLAMINE

pramoxine hydrochloride and hydrocortisone acetate drug variants containing TROLAMINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824
>Company	>Ingredient	>NDC

pramoxine hydrochloride and hydrocortisone acetate drug variants not containing TROLAMINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

pramoxine hydrochloride and hydrocortisone acetate drug variants containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Meda Pharmaceuticals	pramoxine hydrochloride and hydrocortisone acetate	0037-6824
>Company	>Ingredient	>NDC

pramoxine hydrochloride and hydrocortisone acetate drug variants not containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.